Save time and get answers to complex questions with AI chat
Zemdri nce gain exclusivity 2028 patent 2031?When is xarelto's patent set to expire roughly?Xiaflex market launch year?How many years does kadcyla's market exclusivity last?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for acyclovir
In general, acyclovir keeps its effectiveness over long-term use, especially in people with normal immune systems. It’s commonly used for suppression (reducing recurrences) and for ongoing herpes zoster (shingles) treatment with sustained benefit. Key caveats: - Resistance can develop, but is uncommon in healthy individuals. It’s more likely in people with weakened immune systems (e.g., advanced HIV, transplant recipients, or people on chronic immunosuppressants) or in those on long-term therapy. - When resistance occurs, the HSV may be less or not affected by acyclovir. In that case, other antivirals such as foscarnet or cidofovir are usually used. - Prolonged use does not typically cause “tolerance” in the classic sense, but improper dosing, poor adherence, or declining immune function can reduce effectiveness. - Long-term safety: oral acyclovir generally has a good safety profile; IV acyclovir can cause kidney-related side effects, so hydration and dose adjustments may be needed in people with kidney problems. Practical takeaways: - If you notice more frequent or persistent outbreaks or less response to therapy during long-term use, talk to your clinician. They may check for resistance or adjust the regimen. - Ensure adherence, monitor kidney function if you’re at risk, and be aware of potential drug interactions (e.g., with certain other medicines or dehydration can affect kidney excretion). If you want, tell me your situation (immune status, route of administration, dose, and what you’re experiencing), and I can tailor the explanation. This is general information and not a substitute for medical advice.
Other Questions About Acyclovir :